FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387447004: Reserpine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461625016 Reserpine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481538014 Reserpine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
368071000195110 reserpina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
837851000172114 réserpine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Reserpine (substance) Is a Rauwolfia alkaloid (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Resperine measurement Component True Reserpine (substance) Inferred relationship Some 1
Poisoning by reserpine Causative agent (attribute) False Reserpine (substance) Inferred relationship Some
Reserpine 100% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some
Product containing reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 1
Reserpine poisoning Causative agent (attribute) True Reserpine (substance) Inferred relationship Some 1
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some
Product containing chlorothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Product containing hydrochlorothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 1
Product containing hydralazine hydrochloride and hydrochlorothiazide and reserpine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some
Product containing methyclothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Adverse reaction to reserpine Causative agent (attribute) True Reserpine (substance) Inferred relationship Some 1
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Reserpine (substance) Inferred relationship Some 1
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Reserpine (substance) Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Reserpine (substance) Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Reserpine (substance) Inferred relationship Some 2
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some 1
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Reserpine (substance) Inferred relationship Some 1
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Reserpine (substance) Inferred relationship Some 1
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Reserpine (substance) Inferred relationship Some 1
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some 2
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Reserpine (substance) Inferred relationship Some 2
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Reserpine (substance) Inferred relationship Some 1
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some 2
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Reserpine (substance) Inferred relationship Some 2
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Reserpine (substance) Inferred relationship Some 1
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Reserpine (substance) Inferred relationship Some 2
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Reserpine (substance) Inferred relationship Some 2
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Reserpine (substance) Inferred relationship Some 1
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Reserpine (substance) Inferred relationship Some 2
Product containing chlorothiazide and reserpine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Reserpine (substance) Inferred relationship Some 1
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Reserpine (substance) Inferred relationship Some 1
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Reserpine (substance) Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Reserpine (substance) Inferred relationship Some 1
Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Product containing methyclothiazide and reserpine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 1
Product containing hydralazine and hydrochlorothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Product containing only chlorothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Product containing only hydrochlorothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 1
Product containing only methyclothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Product containing only hydralazine and hydrochlorothiazide and reserpine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Reserpine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 1
Product containing only chlorothiazide and reserpine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Product containing only methyclothiazide and reserpine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 2
Product containing only hydrochlorothiazide and reserpine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Reserpine (substance) Inferred relationship Some 1
Chlorothiazide 250 mg and reserpine 125 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Reserpine (substance) Inferred relationship Some 2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Reserpine (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start